The U.S. Food and Drug Administration (FDA) has granted orphan drug status — a designation that aims to speed the development of therapies for rare…
Immune thrombocytopenia
Discussion
Terbutaline, an asthma medication, reduced abnormal immune cell activity linked to platelet destruction in laboratory studies of mouse and patient cells with immune thrombocytopenia…
Discussion
The risk of immune thrombocytopenia (ITP) in children may be elevated shortly after infection with influenza, according to a study based on insurance records…
Discussion
A South Korean study found that people with immune thrombocytopenia (ITP) who received thrombopoietin receptor agonists (TPO-RAs) as second-line ITP treatment had a…
Discussion
The platelet variability index (PVI), a score that measures how low a patient’s platelet count is and how much their number of platelets changes over…
Longer treatment with Wayrilz (rilzabrutinib) helped raise and maintain platelet counts in adults with immune thrombocytopenia (ITP), including some who had not achieved…
Discussion
Nearly half of adults with immune thrombocytopenia (ITP) had cognitive impairment, particularly difficulties with memory, decision-making, and problem solving, a study found. However, the…
Discussion
Even though immune thrombocytopenia (ITP) is a bleeding disorder, people with the disease can paradoxically experience thrombosis — abnormal clots that block blood flow,…
Discussion
The approved injection therapy Nplate (romiplostim) is well tolerated and effective for both adults and children with immune thrombocytopenia (ITP), according to…
Discussion
September is National ITP Awareness Month in the U.S., a time when advocates work to raise awareness and support research into immune thrombocytopenia (ITP).
